Recommendations for when you should get your flu vaccine remain the same – September and October are still considered the optimal times. August vaccinations aren’t recommended unless someone is in their third trimester of pregnancy or for children who will need two doses of the vaccine or those...
The Advisory Committee on Immunization Practices (ACIP) continues to recommend routine yearlyinfluenzavaccination for everyone aged 6 months or older who has no contraindications, according to updatedrecommendationsfor the 2019–2020 influenza season. The recommendations were published online today inMorbidity...
(HealthDay)—Licensed and age-appropriate vaccines for influenza are recommended for the 2021 to 2022 season for all persons aged 6 months or older who do not have contraindications, according to research published in the Aug. 27 issue of the U.S. Center
The new RSV vaccines are expected to be available in fall 2023. CDC Director Rochelle P Walensky, MD, MPH, announced her endorsement of the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendations for use of both new respiratory syncytial virus (RSV) vaccines from GSK and ...
however, despite these already broad recommendations for influenza vaccination, only about half of high-risk individuals typically receive the vaccine, according to the cdc. additionally, the acip noted that emerging data indicate that persons aged 19 to 49 years have been particularly vulnerable to ...
(HealthDay)—Flu vaccines protect children against serious illness, even when the vaccine doesn't match the circulating flu virus, according to a new study that reinforces the importance of flu shots.
Officials also stressed that, unlike other vaccines, insurance coverage of the shots would not be directly tied to the panel's recommendations. Insurerswere requiredto cover the shots immediately after they were greenlighted by the FDA under a law passed earlier in the pandemic. ...
A study published inThe New England Journal of Medicinelast yearsupportedthe ACIP’s recommendations against using LAIV in the U.S., which were based on the unusual finding that the LAIV, despite containing live-attenuated viruses, did not protect...
(PCV21; Capvaxive)opens in a new tab or windowis an option for adults ages 19 years and older who currently have a recommendation to receive a dose of pneumococcal conjugate vaccine. Clinical recommendations that explain the different options of pneumococcal vaccines will be forthcoming, ...
The advisory committee also voted unanimously (14 yes, 0 no) to include the recently approved meningococcal ACWY-TT (MenQuadfi, Sanofi) in the Vaccines for Children program as an option for meningococcal ACWY immunization in accordance with current recommendations for dosing and schedules. The vacc...